Preliminary Program
Go directly to a day's program:
Wednesday | Thursday | Friday | Saturday
All General Sessions to be held in Mediterranean East and Center
| Tuesday, January 15 | |
5:00-7:00pm |
Early Registration |
| Wednesday, January 16 [back to top of page] | |
|
7:30-9:00 |
Registration/Continental Breakfast |
| 9:00-9:10 | Welcome & Explanation of sessions William J. Steinbach, MD |
| 9:10-9:50 | Keynote Interdisciplinary Lecture: Clinical aspergillosis for basic scientists David A. Stevens, MD |
| 9:50-10:30 | Keynote Interdisciplinary Lecture: How can molecular biology help us understand Aspergillus and aspergillosis Aspergillus molecular biology for clinicians Joan W. Bennett, PhD |
10:30-10:55 |
BREAK |
| Molecular Diagnostics | |
| 10:55-11:00 | Session Introduction Moderators: Dennis M. Dixon, PhD and Paul E. Verweij, MD PhD |
| 11:00-11:25 | DNA v. RNA amplification-detection platforms David S. Perlin, PhD |
| 11:25-11:50 | Proteome analysis for pathogenicity and new diagnostic markers Olaf Kniemeyer, PhD |
| 11:50-12:15 | Aspergillus PCR: Formidable challenges and progress Lena Klingspor, MD PhD |
| 12:15-12:40 | Conventional or molecular measurement of Aspergillus load Karl V. Clemons, PhD |
12:40-2:15 |
LUNCH |
| Pathogenesis and Clinical Manifestations in Different Hosts | |
| 2:15-2:20 | Session Introduction Moderators: Scott G. Filler, MD and George A. Sarosi, MD |
| 2:20-2:45 | Invasive aspergillosis in chronic granulomatous disease Brahm H. Segal, MD |
| 2:45-3:10 | Difference in invasive aspergillosis in solid organ transplant recipients Shahid Husain, MD |
| 3:10-3:35 | Invasive disease in patients with leukemia Johan Maertens, MD |
| 3:35-4:00 | Invasive aspergillosis in steroid-treated patients Dimitrios P. Kontoyannis, MD |
4:00-4:25 |
BREAK |
| Neutrophils and Aspergillus | |
| 4:25-4:30 | Session Introduction Moderators: Brahm H. Segal, MD and Michael Kleinberg, MD PhD |
| 4:30-4:55 | Neutrophils and damage during invasive aspergillosis Steve M. Holland, MD |
| 4:55-5:20 | Granulocyte products as alarmins to enhance innate and adaptive immunity De Yang, PhD |
| 5:20-5:45 | Neutrophil contribution to defense against invasive aspergillosis Tobias Hohl, MD, PhD |
5:45-7:15 |
WELCOME RECEPTION |
|
Satellite Symposia Evaluation of Echinocandins for the Treatment of Invasive Aspergillosis Starlight Ballroom – Top of Resort |
|
| 7:30-9:30 | Moderator: William J. Steinbach, MD
Echinocandin activity against Aspergillus and importance of pharmacodynamic optimization Azole resistance Paradoxical echinocandin activity: a limited in vitro phenomenon? |
| Thursday, January 17 [back to top of page] | |
7:30-8:45 |
BREAKFAST |
| 8:00-8:45 | Meet the Professors (parallel sessions)
Illuminating cases for the thinking physician Sexual structures in Aspergillus - morphology, importance, and genomics |
| Utilizing the Aspergillus Cell Wall Mediterranean East and Center |
|
| 8:55-9:00 | Session Introduction Moderators: David S. Perlin, PhD and Jennifer Nielsen Kahn, PhD |
| 9:00-9:25 | Galactomannan: more than one molecule Jean-Paul Latgé, PhD |
| 9:25-9:50 | Chitin synthases of aspergilli: Functions in tip growth and morphogenesis in Aspergillus nidulans Hiroyuki Horiuchi, PhD |
| 9:50-10:15 | Glucan diagnosis for invasive aspergillosis Francisco M. Marty, MD |
10:15-10:40 |
BREAK |
| Aspergillus Sinusitis | |
| 10:40-10:45 | Session Introduction Moderators: John E. Bennett, MD and Kent Sepkowitz, MD |
| 10:45-11:10 | Controversies surrounding categorization of fungal sinusitis Arunaloke Chakrabarti, MD |
| 11:10-11:35 | Management of invasive Aspergillus sinusitis Richard D. deShazo, MD |
| 11:35-12:05 | Aspergillus sinusitis in animals and parallels in human disease Michael J. Day, PhD |
| 12:05-12:30 | Allergic Fungal Sinusitis Mark S. Schubert, MD |
12:30-1:50 |
LUNCH |
| Selected Talks from Junior Investigators | |
| 1:50-1:55 | Session Introduction Moderators: William J. Steinbach, MD and Karl V. Clemons, PhD |
| 1:55-2:05 | The role of sialic acids on the surface of Aspergillus fumigatus and the characterization of an a. Fumigatus sialidase |
| 2:05-2:15 | The timing of myeloid cell depletion relative to infection determines the outcome of invasive Aspergillosis |
| 2:15-2:25 | Human platelets influence cell wall assembly in Aspergillus fumigatus |
| Aspergillus Species / Strain Differences | |
| 2:25-2:30 | Session Introduction Moderators: Scott E. Baker, PhD and Katsu Kamei, MD, PhD |
| 2:30-2:55 | Criteria for Aspergillus speciation: Utrecht meeting summary Robert A. Samson, PhD |
| 2:55-3:20 | MLST vs. Microsatellites Corne Klaasen, PhD |
| 3:20-3:45 | Comparison of the two sequenced A. fumigatus strains Natalie D. Federova, PhD |
| 3:45-4:10 | A. terreus complex S. Arun Balajee, PhD |
4:10-4:35 |
BREAK |
| Vaccine and T Cell Immunity | |
| 4:35-4:40 | Session Introduction Moderators: Luigina Romani, MD, PhD and Jill Adler-Moore, MD |
| 4:40-5:05 | Cultivated TH1 cells Thomas Lehrnbecher, MD, PhD |
| 5:05-5:30 | Host response signatures to invasive aspergillosis Teresa Zelante, PhD |
| 5:30-5:55 | Vaccine progress James I. Ito, MD |
| 6:00-7:20 | POSTER SESSION #1 with drinks/snacks Session 1 - Posters 1-36 Session 2 - Posters 37-97 |
| Satellite Symposia Risk Stratification for Invasive Aspergillosis and Prophylaxis Starlight Ballroom (Top of Resort) |
|
| 7:30-9:30 | Risk stratification for invasive aspergillosis: Early assessment of host susceptibility Thomas F. Patterson, MD Prophylaxis limitations: Challenges in the management of invasive Aspergillosis Pranatharthi H. Chandrasekar, MD Interactive case studies: Improving clinical outcomes in invasive Aspergillosis Nina Singh, MD |
| Friday, January 18 [back to top of page] | |
7:30-8:45 |
BREAKFAST |
| 8:00-8:45 | Meet the Professors (parallel sessions)
Recognizing therapeutic failure - case illustrations and challenges Inflammation in Aspergillus immunology |
| Alternative Imaging in Invasive Aspergillosis Mediterranean East and Center |
|
| 8:55-9:00 | Session Introduction Moderators: Dimitrios P. Kontoyiannis, MD and Jose G. Montoya, MD |
| 9:00-9:25 | Galactomannan and beyond: MRI and PET for diagnosis Elias Anaissie, MD |
| 9:25-9:50 | Functionalized nanocarriers to image and target fungi infected immune cells Suresh P. Vyas, PhD |
| 9:50-10:15 | Live-cell imaging of Aspergillus in vitro Nick Read, PhD |
| 10:15-10:40 | Imaging in animals with invasive aspergillosis Thomas J. Walsh, MD |
10:40-11:05 |
BREAK |
| Controlling Aspergillus in buildings | |
| 11:05-11:10 | Session Introduction Moderators: Thomas M. Chiller, MD and Elias J. Anaissie, MD |
| 11:10-11:35 | Infection control and HICPAC guidelines David J. Weber, MD, MPH |
| 11:35-12:00 | Nosocomial asperigllosis: review and building construction cases Donna Haiduven, PhD |
| 12:00-12:30 | Sick building debate: Is mould the cause? Abba I. Terr, MD |
1:00-6:00 |
LUNCH and CHOICE OF THREE TOURS |
| 6:00-7:30 | POSTER SESSION #2 with drinks/snacks Session 1 - Posters 1-36 Session 2 - Posters 37-97 |
|
Satellite Symposia Invasive Fungal Infections in Patients With Hematologic Malignancies: Will New Strategies For Treatment Lead to New Opportunities for Improving Patient Outcome? Starlight Ballroom – Top of Resort |
|
| 7:30-9:30 | Amphotericin B: Past, present and future Michael Kleinberg, MD PhD Newer antifungal delivery systems Cerebral aspergillosis: Tissue penetrance is the key |
| Saturday, January 19 [back to top of page] | |
7:30-8:45 |
BREAKFAST |
| 8:45-8:55 | Awards and Scholarships Presentation David A. Stevens, MD Mediterranean East and Center |
| Aspergillus and Asthma / ABPA Cystic Fibrosis Foundation Symposia |
|
| 8:55-9:00 | Session Introduction Moderators: Richard B. Moss, MD and David W. Denning, MD |
| 9:00-9:25 | Phenotypes of severe asthma Sally E. Wenzel, MD |
| 9:25-9:50 | Differences in the immunobiology of Aspergillus colonization and ABPA? Jay K. Kolls, MD |
| 9:50-10:15 | Regulation of immunity in bronchiectasis and ABPA Rosemary Boyton, MD |
| 10:15-10:40 | Mechanisms behind the cystic fibrosis - ABPA link Dominik Hartl, MD |
10:40-11:05 |
BREAK |
| Secondary Metabolites from Aspergillus | |
| 11:05-11:10 | Session Introduction Moderators: Joan Bennett, PhD and June Kwon-Chung, PhD |
| 11:10-11:35 | Genomic insights about secondary metabolite gene clusters/pathways William C. Nierman, PhD |
| 11:35-12:00 | Aspergillus metabolites in vivo Robert A. Cramer, Jr., PhD |
| 12:00-12:25 | Aspergillus and biotechnology Scott Baker, PhD |
| 12:25-12:50 | Metabolomics of A. fumigatus Jens Frisvad, PhD |
12:50-2:15 |
LUNCH |
| Aspergillus growth towards pathogenicity | |
| 2:15-2:20 | Session Introduction Moderators: Reinhard Fischer, PhD and Nir Osherov, PhD |
| 2:20-2:45 | Interaction of Aspergillus with human bronchial mucosa Ryoichi Amitani, PhD |
| 2:45-3:10 | Lung epithelial cell invasion William W. Hope, MD, PhD |
| 3:10-3:35 | Biofilm formation by Aspergillus Gordon Ramage, PhD |
| 3:35-4:00 | Differences in pathogenicity and clinical syndromes due to A. fumigatus and A. flavus Alessandro C. Pasquallotto, MD PhD |
| 4:00-4:05 | Conference Farewell David W. Denning, MD |
| 5:00- 5:45 | Planning for AAA 2010 Conference Open planning session (everyone invited) to discuss ideas and plans for next meeting in 2010 |